By delivering high-quality clinical data that has been pre-cleaned, our e-clinical systems make your study significantly more productive.
Configure studies quickly with our simple and inbuilt interface without depending on programming.
Form rules like edit checks and conditional branching along with user friendly data entry forms empower users to enter data rapidly while ensuring accuracy.
Clinion a complete and integrated environment for the configuration,
data capture and data management of clinical trials.
Clinion CDMS is a cloud-based platform that enables easy capture of high quality clean data. A clinical trial begins and ends with clean and high quality data. This data is collected in the most streamlined and efficient manner possible. Clinion’s CDMS is secure and flexible enough to meet any workflow requirements.
Design multiple studies using the eCRF Designer and Global Library, followed by logical steps to create your study. The entire CRF is generated by the system once the study and form information is provided.
Now that a design is set-up, both you and your investigators can enter data according to assigned access . This can be accessed from Work Area, PC or a Tablet as required.
The ability to monitor progress and troubleshoot is the Critical part in any CDMS application. Query management and resolution tool enables different roles/users to troubleshoot queried data. All data is mapped and an audit trail provides reporting capability. Results can be filtered to focus the information as required.
Thought Exploration Solution
Clinion global library is now integrated with CDISC libraries so that CDISC annotations can be mapped to CRF fields during eCRF creation. Features of CDISC integration include:
Quick and Faster
Doesn’t depend on programmers
or other contractors
Ensure precision with real-time
edit checks, skip logic, and other highlights
Adequate monitoring with
Unite with CTMS, RBM,
SAE database and others
Workable from multiple
devices and locations
Simple and easy to
Clinion has been utilized for a large number of Phase I – Phase IV studies. Clinion has been deployed for FDA, EU, Israel & DCGI regulatory studies. The major therapeutic areas covered by Clinion are: